Literature DB >> 8757881

Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome.

R L Deresiewicz1, J Flaxenburg, K Leng, D L Kasper.   

Abstract

To explore whether a novel staphylococcal clone or structural variant of toxic shock syndrome toxin 1 is associated with Kawasaki syndrome, six toxigenic strains of Staphylococcus aureus from Kawasaki syndrome patients were studied. The strains were divisible into two groups based on phenotypic and genotypic characteristics and are therefore unequivocally not clonal. Portions of the tstH genes of each strain were sequenced. Three were sequenced in their entirety, while the remainder were sequenced from codon 66 to codon 137 of the mature protein only. Two of the former group differed slightly in the sequences of their signal peptides relative to the sequence published for the tstH signal peptide. Those differences did not affect toxin processing or secretion. The sequenced portions of the regions encoding mature toxic shock syndrome toxin 1 were identical in all six strains and corresponded exactly to the published sequence of tstH. No evidence was found for the existence of a structural variant of tstH uniquely associated with Kawasaki syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757881      PMCID: PMC174235          DOI: 10.1128/iai.64.8.3394-3396.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Centers for Disease Control (CDC) case definition for Kawasaki syndrome.

Authors:  A M Rauch; E S Hurwitz
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

2.  Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.

Authors:  P K Lee; B N Kreiswirth; J R Deringer; S J Projan; W Eisner; B L Smith; E Carlson; R P Novick; P M Schlievert
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1.

Authors:  D A Blomster-Hautamaa; B N Kreiswirth; J S Kornblum; R P Novick; P M Schlievert
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

4.  Toxic shock syndrome toxin 1 is encoded by a variable genetic element.

Authors:  B N Kreiswirth; S J Projan; P M Schlievert; R P Novick
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

5.  Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.

Authors:  P M Schlievert; D A Blomster
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Toxic shock syndrome surveillance in the United States, 1980 to 1981.

Authors:  A L Reingold; N T Hargrett; K N Shands; B B Dan; G P Schmid; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Mutations affecting the activity of toxic shock syndrome toxin-1.

Authors:  R L Deresiewicz; J Woo; M Chan; R W Finberg; D L Kasper
Journal:  Biochemistry       Date:  1994-11-01       Impact factor: 3.162

Review 8.  Kawasaki syndrome.

Authors:  A H Rowley; F Gonzalez-Crussi; S T Shulman
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

9.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

Authors:  J Abe; B L Kotzin; K Jujo; M E Melish; M P Glode; T Kohsaka; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Genetic studies on Staphylococcal strains from patients with toxic shock syndrome.

Authors:  B N Kreiswirth; R P Novick; P M Schlievert; M Bergdoll
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

View more
  1 in total

Review 1.  Superantigens and nasal polyps.

Authors:  Claus Bachert; Thibaut van Zele; Philippe Gevaert; Lore De Schrijver; Paul Van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.